104 related articles for article (PubMed ID: 9614338)
1. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein.
Farrell PJ
Trends Microbiol; 1998 May; 6(5):175-7; discussion 177-8. PubMed ID: 9614338
[No Abstract] [Full Text] [Related]
2. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
[TBL] [Abstract][Full Text] [Related]
3. LMP1 structure and signal transduction.
Eliopoulos AG; Young LS
Semin Cancer Biol; 2001 Dec; 11(6):435-44. PubMed ID: 11669605
[TBL] [Abstract][Full Text] [Related]
4. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.
Erickson KD; Martin JM
J Virol; 2000 Jan; 74(2):1057-60. PubMed ID: 10623774
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.
Kieser A; Kilger E; Gires O; Ueffing M; Kolch W; Hammerschmidt W
EMBO J; 1997 Nov; 16(21):6478-85. PubMed ID: 9351829
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity.
Bloss T; Kaykas A; Sugden B
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3227-3232. PubMed ID: 10567655
[TBL] [Abstract][Full Text] [Related]
7. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
8. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.
Fischer N; Kopper B; Graf N; Schlehofer JR; Grässer FA; Mueller-Lantzsch N
Virus Res; 1999 Mar; 60(1):41-54. PubMed ID: 10225273
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus: LMP1 masquerades as an active receptor.
Eliopoulos AG; Rickinson AB
Curr Biol; 1998 Mar; 8(6):R196-8. PubMed ID: 9512412
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
Ishikawa C; Mori N
Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
[TBL] [Abstract][Full Text] [Related]
12. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus regulates STAT1 through latent membrane protein 1.
Richardson C; Fielding C; Rowe M; Brennan P
J Virol; 2003 Apr; 77(7):4439-43. PubMed ID: 12634403
[TBL] [Abstract][Full Text] [Related]
15. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling.
Kaykas A; Worringer K; Sugden B
J Virol; 2002 Nov; 76(22):11551-60. PubMed ID: 12388716
[TBL] [Abstract][Full Text] [Related]
16. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
17. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
[TBL] [Abstract][Full Text] [Related]
18. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1.
Yoshizaki T
Histol Histopathol; 2002; 17(3):845-50. PubMed ID: 12168795
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
[TBL] [Abstract][Full Text] [Related]
20. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]